Perspective Therapeutics Inc. (CATX) — Cash Flow Reinvestment Rate

Latest as of September 2024: 17.66x

Perspective Therapeutics Inc. (CATX) has a Cash Flow Reinvestment Rate of 17.66x as of September 2024, reinvesting $59.45 Million (capex $29.71 Million plus investments $-29.74 Million) from operating cash flow of $3.37 Million. Explore Perspective Therapeutics Inc. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

17.66x
(Capex + Investments) / Operating CF

Total Reinvested

$59.45 Million
Capex + Investments

Operating Cash Flow

$3.37 Million
USD

Capital Expenditures

$29.71 Million
USD

Perspective Therapeutics Inc. Cash Flow Reinvestment Rate (1999–2001)

Historical reinvestment intensity for Perspective Therapeutics Inc. across 4 annual periods. Also explore CATX current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Perspective Therapeutics Inc. (1999–2001)

Year-by-year capital reinvestment analysis for Perspective Therapeutics Inc.. For live market cap and broader valuation context, see CATX stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2001 0.13x $48.81K $365.34K $48.81K ▲ +0.0%
2000 0.13x $48.81K $365.34K $48.81K ▼ -76.9%
1999 0.58x $159.58K $275.97K $159.58K ▲ +0.0%
1999 0.58x $159.58K $275.97K $159.58K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow